Subunit vaccine for treatment or prevention of a respiratory tract infection
US12162909B2 · kind B2 · utility
0Cited by
3References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 24, 2023 |
| Grant date | Dec 10, 2024 |
| Priority date | — |
| Expiry date | Oct 24, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/18334
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to modified hMPV F proteins stabilized in the pre-fusion conformation as vaccine candidates.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.